Inhalation

INH0426

Issue link: https://www.e-digitaleditions.com/i/1544305

Contents of this Issue

Navigation

Page 13 of 47

This section provides information that may be useful in research and development or manufacturing. Content is provided by the companies listed. No endorsement or preference is intended. 12 April 2026 Inhalation ISSUE FOCUS Instruments This section of Inhalation provides information that may be useful in research and development or manufacturing. Content is provided by the companies listed. No product endorsement or preference is intended. Modular automation solutions OINDP testing workflows are inherently complex, extending across sample preparation, actuation, drug recovery and data analysis. Introducing modular automation at defined stages can reduce operator- dependent variability and improve repeatability with- out requiring full laboratory workflow redesign. When supported by structured software such as Inhalytix ® +, test parameters, results and reporting outputs remain clearly linked, helping laboratories maintain trace- ability from execution through final approval, while strengthening confidence in reported aerodynamic particle size distribution (APSD) and delivered dose uniformity (DDU) data. Copley Scientific UK: +44 1159 616229 info@copleyscientific.com www.copleyscientific.com Enhancing IVIVC through advanced test instrumentation Improving in vitro/in vivo correlation (IVIVC) for inhalation products requires test instrumentation that more closely reflects real patient use. Breathing sim- ulators capable of reproducing variable tidal profiles help move beyond fixed-flow aerodynamic particle size distribution (APSD) testing, offering a more rep- resentative assessment of aerosol delivery. Advanced geometries such as the Alberta Idealized roat (AIT) and Alberta Idealized Nasal Inlet (AINI) provide ana- tomically relevant pathways for particle deposition studies. Lung diffusion models further support under- standing of dissolution and absorption behavior, while facemask fit evaluation helps account for potential drug losses. Together, these tools strengthen the link between laboratory measurements and clinical perfor- mance. Learn more: https://tsi.news/46QbPB5. MSP™, a Division of TSI ® US: +1 651 287-8100 mspsales@tsi.com www.tsi.com

Articles in this issue

Links on this page

view archives of Inhalation - INH0426